Regeneron Pharmaceuticals (NQ: REGN )
1,051.03
+0.17
(+0.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals![]() ![]() ![]() ![]() ![]() ![]() ![]()
Regeneron's Bispecific Antibodies Show Encouraging Anti Tumor Activity
September 12, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
Via Benzinga
![]() ![]()
Intellia Therapeutics Posts Back To Back Positive Data From Gene Editing Therapies
September 16, 2022
Via Benzinga
![]() ![]()
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via Benzinga
![]() ![]() ![]()
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|